| |||||||||
Type Mutant Strain; Targeted Mutation; Additional information on Genetically Engineered Mutant Mice. Species laboratory mouse Generation N7F?+N1+N1p (11-SEP-05) Donating Investigator Norma Andrews, Yale University School of Medicine Description
At birth, mice homozygous for the targeted allele are viable, fertile, normal in size and do not display any gross physical or behavioral abnormalities. Although Northern analysis fails to detect full-length transcripts, two minor alternatively spliced (alpha and beta) isoforms are generated. Protein product is not detected. Reproductive capacity appears to decline faster in mutant mice. The average litter size in +6 month-old mice is ~3 in mutants compared to ~7 in wild type mice. Lysosomal exocytosis and plasma membrane resealing in response to membrane wounding is impaired in mouse embryo fibroblasts derived from mutants. Histological analysis of mutants 14 weeks of age indicates that most tissues appear normal with the exception of enhanced accumulations of connective tissue elements, indicative of fibrosis, in skeletal muscle and skin. Examination of skeletal muscle from younger animals (4 weeks of age) reveals evidence of fiber degeneration and inflammation. Strong anti-nuclear antibody response is detected in serum at 19 and 44 weeks of age, but not in 8-week-old animals. Elevated levels of serum creatine kinase, a diagnostic marker for muscle fiber injury, are also observed. Decreased forelimb grip is observed in mutant mice more than 19 weeks of age. This mutant strain may be useful in studies examining the mechanisms of membrane homeostasis, secretion and autoimmunity.Development
A targeting vector containing a loxP-flanked neomycin resistance was used to disrupt exons 4-5 of the targeted gene. This region encodes the C2A calcium binding domain. The construct was electroporated into 129S1/Sv-p+ Tyr+ KitlSl-J/+ derived W9.5 embryonic stem (ES) cells. Correctly targeted ES cells were injected into C57BL/6 blastocysts.
| Control | ||
|---|---|---|
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
Strains carrying other alleles of Syt7
006388 B6;129-Syt7tm1Sud/J 006389 B6;129-Syt7tm2Sud/J View Strains carrying other alleles of Syt7 (2 strains)
Congenic Nomenclature
Genetic Quality Control Annual Report
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
Syt7tm1Nan/Syt7tm1Nan
involves: 129S1/Sv * C57BL/6
- cellular phenotype
- abnormal cell physiology (MGI Ref ID J:85201)
- embryo fibroblasts are resistant to invasion by Trypanosoma cruzi
- failure of exocytosis and wound resealing in embryo fibroblasts
- immune system phenotype
- increased anti-nuclear antigen antibody level (MGI Ref ID J:85201)
- antinuclear antibody response in serum by 19 weeks
- increased inflammatory response (MGI Ref ID J:85201)
- myositis (MGI Ref ID J:85201)
- extensive endomysial cellular infiltration at week 4
- week 8, scattered foci of inflammation
- invasion of degenerating muscle fibers by macrophages and eosinophiles
- inflammatory cells less abundant as mice age but fibrosis detectable until week 44
- increased susceptibility to autoimmune disorder (MGI Ref ID J:85201)
- similarities to human autoimmune polymyositis/dermatositis
- muscle phenotype
- abnormal skeletal muscle morphology (MGI Ref ID J:85201)
- extensive endomysial cellular infiltration at 4 weeks
- by 8 weeks, mast cells and bundles of collagen fibers found in endomysial space
- fiber degeneration
- skeletal muscle interstitial fibrosis (MGI Ref ID J:85201)
- muscle weakness (MGI Ref ID J:85201)
- decreased forelimb grip strength after 19 weeks
- myositis (MGI Ref ID J:85201)
- extensive endomysial cellular infiltration at week 4
- week 8, scattered foci of inflammation
- invasion of degenerating muscle fibers by macrophages and eosinophiles
- inflammatory cells less abundant as mice age but fibrosis detectable until week 44
- reproductive system phenotype
- abnormal fertility/fecundity (MGI Ref ID J:85201)
- reproductive capacity declines faster with age (litters of 3 at 6 months as opposed to 7 for wild-type mice)
- normal fertility otherwise
- other phenotype
- fibrosis (MGI Ref ID J:85201)
- enhanced accumulation of connective tissue elements seen histologically in the skin and skeletal muscle (fibrosis)
- increased collagen deposition not seen in other tissues
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:Syt7tm1Nan related
Immunology and Inflammation Research
Autoimmunity (anti-nuclear antibodies)
Inflammation
| Allele Symbol | Syt7tm1Nan | ||
|---|---|---|---|
| Allele Name | targeted mutation 1, Norma W Andrews | ||
| Allele Type | Targeted (knock-out) | ||
| Common Name(s) | Syt VII -; | ||
| Mutation Made By | Norma Andrews, Yale University School of Medicine | ||
| Strain of Origin | 129S1/Sv-Oca2<+> Tyr<+> Kitl<+> | ||
| ES Cell Line Name | W9.5/W95 | ||
| ES Cell Line Strain | 129S1/Sv-Oca2<+> Tyr<+> Kitl<+> | ||
| Gene Symbol and Name | Syt7, synaptotagmin VII | ||
| Chromosome | 19 | ||
| Gene Common Name(s) | AI851541; B230112P13Rik; IPCA-7; MGC150517; PCANAP7; RIKEN cDNA B230112P13 gene; SYT-VII; expressed sequence AI851541; | ||
| Molecular Note | A loxP flanked neomycin resistance cassette replaced most of exon 4 and exon 5. In the process a stop codon was generated in exon 4 after the codon for amino acid 83. Absence of the 1.2kb mRNA for the major isoform of this gene was established by Northern blot analysis. Lack of protein product was confirmed by Western blot analysis. However, a truncated protein may be produced. [MGI Ref ID J:85201] | ||
Genotyping Protocols
Syt7tm1Nan, STD PCR, vers. 1
Helpful Links
Optimizing PCR Protocols
Chakrabarti S; Kobayashi KS; Flavell RA; Marks CB; Miyake K; Liston DR; Fowler KT; Gorelick FS; Andrews NW. 2003. Impaired membrane resealing and autoimmune myositis in synaptotagmin VII-deficient mice. J Cell Biol 162(4):543-9. [PubMed: 12925704] [MGI Ref ID J:85201]
Syt7tm1Nan relatedChan WT; Sherer NM; Uchil PD; Novak EK; Swank RT; Mothes W. 2008. Murine leukemia virus spreading in mice impaired in the biogenesis of secretory lysosomes and Ca2+-regulated exocytosis. PLoS ONE 3(7):e2713. [PubMed: 18629000] [MGI Ref ID J:139279]
Czibener C; Sherer NM; Becker SM; Pypaert M; Hui E; Chapman ER; Mothes W; Andrews NW. 2006. Ca2+ and synaptotagmin VII-dependent delivery of lysosomal membrane to nascent phagosomes. J Cell Biol 174(7):997-1007. [PubMed: 16982801] [MGI Ref ID J:115013]
Zhao H; Ito Y; Chappel J; Andrews NW; Teitelbaum SL; Ross FP. 2008. Synaptotagmin VII regulates bone remodeling by modulating osteoclast and osteoblast secretion. Dev Cell 14(6):914-25. [PubMed: 18539119] [MGI Ref ID J:137198]
Colony Maintenance
Breeding & Husbandry This strain originated on a B6;129S1 background and has been backcrossed to C57BL/6 for 7 generations before being made homozygous. When maintained in a live colony, this strain is maintained by homozygous matings. Diet Information LabDiet® 5K52/5K67
| Pricing for USA, Canada and Mexico shipping destinations |
|
*Price(s) in US dollars ($)
Weeks of Age Price* Gender Cryorecovery Fee $1900.00 Cryopreserved Embryos Fee $1600.00
| Pricing for International shipping destinations |
|
*Price(s) in US dollars ($)
Weeks of Age Price* Gender Cryorecovery Fee $2470.00 Cryopreserved Embryos Fee $2080.00
| Standard Supply | Repository-Cryopreserved. Must Be Recovered. Please refer to pricing and supply notes for further information. |
|---|---|
| Supply Notes |
|
| Control | ||
|---|---|---|
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form
For additional Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. THE LABORATORY EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of MICE, products or services, The Jackson Laboratory will, at its option, provide credit or replacement for the MICE or product received or the services provided.
In no event shall The Jackson Laboratory, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, products or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of The Jackson Laboratory, its agents or employees. In purchasing or receiving MICE, products or services from The Jackson Laboratory, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges The Jackson Laboratory from all such causes of action or damages, and further agrees to defend and indemnify The Jackson Laboratory from any costs or damages arising out of any third party claims.
MICE and biological materials are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to The Jackson Laboratory’s MICE, products and services. In addition, special terms and conditions of sale of certain MICE, products and services may be set forth separately in The Jackson Laboratory web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, products and services by The Jackson Laboratory, and by its licensees and distributors.
Acceptance of delivery of MICE, products or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on The Jackson Laboratory, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, products services by The Jackson Laboratory.